Academic Detailing (AD): A New Resource From AR-IMPACT

Slides:



Advertisements
Similar presentations
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Advertisements

Sublingual Buprenorphine and Pain
Transitional care management (TCM): A team approach to facilitating transitions of care in a Gerontology Clinic Carol O’Leary, Jeffrey Kochka, Virginia.
IMPROVING DIABETES MANAGEMENT IN PRIMARY CARE
Introduction to Pain/Opioid Management
Treating Chronic Pain in Adolescents Amanda Bye, PsyD, Behavioral Medicine Specialist Collaborative Family Healthcare Association 15 th Annual Conference.
The Vermont Academic Detailing Program (VT AD) Updated September 2011.
Medical Cannabis in Maryland Presentation to University of Maryland Medical School Quarterly Meeting October 8, 2015 by Deborah Miran Commissioner Maryland.
An unpleasant sensory or emotional experience associated with actual or potential tissue damage The World Health Organization (WHO) has stated that pain.
100 years of living science Chronic disease management in primary care: lessons to be learnt Dr Shamini Gnani November 2007, Mauritius.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
A Community Mobilized to Take Action Marin County, California Kristen M Law, MA.
Health Literacy Summit Madison, WI
Patient Experience of Care Surveys
Care Transitions for Medication Safety in the Community
Choosing Wisely Pharmacy’s Role and Recommendations Mary Wong
Comparison of Opioid Prescribing Guidelines Violations by Clinical Speciality Chia-Chen Teng1,2, Christy Porusnik3, Erin Johnson4, Robert Rolfs3, Jonathan.
Draft Primary Care Strategy
Funded by the NIHR HSDR Programme
The Role of Dentists in Preventing Opioid Abuse
ACT with Mindfulness: Piloting
Strategies to Modernize State Medicaid Programs, Utah’s Medicaid Transformation By Lisa V. Hulbert R.Ph. Transformation Program Manager Utah Medicaid.
Jessica E. Bates, Pharm.D. PGY-1 Pharmacy Resident
Opioid Management in Primary Care Michael Parchman, MD, MPH
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
Dedicated to Addressing Diabetes
6-Building Block Workshop
Nebraska Prescription Drug Overdose Prevention Program Efforts
Drug Diversion and Substance Use Disorder Management: Optimizing Collaboration Across the Continuum Michael O’Neil, Pharm.D. Professor and Chair, Department.
Larissa Grigoryan, MD, PhD Family and Community Medicine
MacColl Center for Health Care Innovation
An overdose Reduction PlaN
Clinical Pharmacy II.
Death with Dignity Introduction.
Death with Dignity Introduction.
A Recommendation from Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from ACOP and APS By Rhys Dela Cruz, Angela Hickey,
Opioid Crisis A Call to ACTION
Impact of Academic Detailing in the Chicagoland Region: A Pilot Study
The Six Building Blocks
ROOM project Addressing the Opioid Epidemic in the U.P.
Opioid Prescribing & Monitoring
Department of Health Management and Informatics
A State Targeted Response to the Opioid Crisis:
What Works? Evidence-Based Practices for Treating Opioid Use Disorder
Bevin K. Shagoury, Communications & Education Director
Severe Chronic Conditions Substantial Service Needs
Opioids in Butte County
Review why we’re doing this work Display survey results
Knowledge Utility results from Rigor in Methods & Relevance in Content
Prescription Drug Monitoring Program
The MRMC Experience: ED Initiatives to Reduce Opioid Rx Rates
The Edward Jenner Programme Challenges in Healthcare
Evaluation of Immunization Standing Orders Programs in North Carolina Hospitals Presented by Wayne L. Anderson Ph.D.1, Amanda Honeycutt Ph.D.1, Kathleen.
Big Mental Health Survey: Senedd Briefing
Opioid Use Disorders: Recognition and Pharmacotherapy Review
What do we mean by opioid sparing and what are its potential individual and societal benefits? Eric C. Strain, M.D. Johns Hopkins University School.
Prescription Drug Monitoring Program
Coordinated Seniors Care Initiative Completing the Circle of Care: Specialists + PMHs + PCNs October 29th, 2018.
2019 Improvement Activities
Offer the National DPP lifestyle change program to your patient population Thank you for considering the National Diabetes Prevention Program lifestyle.
A Note to Facilitators Dear Facilitator, Thank you for using Rural PREP’s materials to create an active learning experience for your site. Use this slide.
Unintended Consequences of Opioid Policies
Massachusetts Consultation Service for the Treatment of Addiction and Pain (MCSTAP) Offers real-time phone consultation to primary care practices on safe.
Data Sources ADH: Other AR Data: National: Vital Statistics PDMP
SAMPLE ONLY Dominion Health Center: Your Community Partner for Excellent Care (or another defining message) Dominion Health Center is a community health.
SAMPLE ONLY Dominion Health Center: Your Community Healthcare Home (or another defining message) Dominion Health Center is a community health center.
Tapering and Discontinuing Chronic Opioid Therapy
Opioid Stewardship Johnathan Goree, MD
Dementia: Barriers to accessing quality End of Life Care and Role of Admiral Nurses Chris O’Connor Consultant Admiral Nurse Dementia Fellow   
Presentation transcript:

Academic Detailing (AD): A New Resource From AR-IMPACT Teresa Hudson, PharmD, PhD Associate Professor, Department of Psychiatry CE Credits: TEXT: 501-406-0076  Activity Code:30083-24581

Set Up for Using Poll Everywhere Text to this number: 22333 Text this message: Teresahudson735

https://www. polleverywhere https://www.polleverywhere.com/multiple_choice_polls/DdDTas4gsG36RzxCrUwvA

Goals of AR IMPACT-AD Program Decrease high-risk prescribing of opioids Daily dose >50 MME Prescribing for longer than 3-7 days Prescribing to patients with history of SUD Increase use of other pain management strategies NSAID/Acetaminophen Other medications for neuropathic pain Physical therapy Exercise: walking, stretching, etc.

Presentation Objectives: After attending this presentations, participants will be able to: Define academic detailing and understand how this strategy is relevant to prescribing opioid medications Discuss evidence for effectiveness of academic detailing Understand the implementation of academic detailing as a resource from AR-IMPACT

What is Academic Detailing (AD)? An innovative, 1-on-1 outreach education technique that helps clinicians provide evidence-based care to their patients. Gerry Avorn, MD Patterned after detailing visits used by pharmaceutical industry Focus is on evidence for a particular treatment AD visits may also focus on lack of evidence for a particular treatment During visit, implementation of evidence-based treatments to replace non- evidence based treatment are discussed

Description of Academic Detailing Visit Short one-on-one meeting between detailer and prescribers Usually 10-20 minutes Focus on 1-3 messages around a particular topic. For example, how to wean opioids and use of non-opioid analgesics Can be tailored to the patient population of that prescriber Often Delivered by a pharmacist Many programs use a range of healthcare professionals along with health educators Usually involves some written materials that may be retained by the prescriber

Effectiveness of Academic Detailing Widely used by VA to: Decrease high dose antipsychotic Decrease antipsychotic polypharmacy Decrease high risk opioid prescribing Increase CPT for PTSD Other studies have shown AD to be effective in: Increasing pneumococcal vaccination – (Caffrey et al 2017) Increased use of NSAIDs for pain – (Bruyndoncks et al 2018) Decreasing use of cerebral and peripheral vasodilators, oral cephalosporin antibiotics, and propoxyphene (Avorn and Soumerai 1983)

Why AR IMPACT is Offering AD: https://www.cdc.gov/drugoverdose/maps/rxstate2017.html National average for rate of opioid prescribing is 79.3 opioid prescriptions per 100 persons Arkansas’ current rate of opioid prescribing is 102-111/100 persons 66/75 Arkansas counties have rate higher than national average 86% of heroin users report previous use of prescription opioids Sources: family, friends, personal prescriptions

Opioid Overdose Deaths

Arkansans are at risk for Chronic Pain:

Prevalence¶ of Self-Reported Obesity Among U. S Prevalence¶ of Self-Reported Obesity Among U.S. Adults by State and Territory, BRFSS, 2017 ¶ Prevalence estimates reflect BRFSS methodological changes started in 2011. These estimates should not be compared to prevalence estimates before 2011. *Sample size <50 or the relative standard error (dividing the standard error by the prevalence) ≥ 30%.

AR IMPACT-AD Program Funded through grant from CDC to Arkansas Dept. of Health Subcontract to UAMS – AR IMPACT team Timeframe: expected to end September 30, 2019 Team: AR IMPACT team – review all AD materials AR IMPACT Pain Specialist available for one-on-one consultation Emergency Department Physician available for one-on-one consultation Primary Academic Detailer: Armenda Young, PharmD Project Manager: Amanda Lunsford, MA

AR IMPACT-AD Program Features: Materials/messages focused common opioid prescribing problems: Tapering strategies for opioids Non-opioid analgesic medications for pain Non pharmacotherapy options for pain Communicating with patients about pain PDMP data used to identify prescribers who prescribe: High MME daily dose High number of pills for chronic use Have large number of patients receiving opioids

AR IMPACT-AD Program Features: Make appointment with prescriber at their convenience Visit in person to talk about challenges in pain management Discuss materials/messages relevant to that prescriber Prescribers will have the opportunity to give feedback on visit Suggest other topics Request visits if needed

Evaluating AR IMPACT–AD Program Short email survey to prescribers who receive AD visit Evaluation of change in prescribing practices Tracking outcome of visits Tracking requests for additional visits on specific topics Roll-out in “step-wise” fashion to compare prescribing rates at places who did and did not receive AD.

https://www.polleverywhere.com/discourses/keqPCWx4BveHapZT5rQ9J

https://www.polleverywhere.com/discourses/snCbSkyP8nZ1OAq3cQJ9L